Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Yasushi Shimizu"'
Autor:
Sadakatsu Ikeda, Ryo Kudo, Yamato Yamashita, Toshio Kubo, Yukiko Mori, Yohei Harada, Hidekazu Shirota, Hideyuki Hayashi, Masayuki Kano, Yasushi Shimizu, Eri Ishibashi, Ukihide Tateishi, Akihiro Hirakawa, Hirotoshi Akita, Hisahiro Matsubara, Hiroshi Nishihara, Chikashi Ishioka, Naoko Sueoka-Aragane, Manabu Muto, Shinichi Toyooka
Publikováno v:
Journal of Clinical Oncology. 40:3131-3131
3131 Background: Human epidermal growth factor receptor 2 (HER2) gene amplification or mutations have emerged as oncogenic drivers and therapeutic targets not limited to breast and gastric cancers, but also in a variety of cancers. Despite its consid
Autor:
Akihiro Hirakawa, Manabu Muto, Toshio Kubo, Hisahiro Matsubara, Yukiko Mori, Yasushi Shimizu, Hirotoshi Akita, Sadakatsu Ikeda, Eri Ishibashi, Ryo Kudo, Hiroshi Nishihara, Satoshi Miyake, Yohei Harada, Chikashi Ishioka, Naoko Sueoka-Aragane, Hidekazu Shirota, Masayuki Kano, Ukihide Tateishi, Shinichi Toyooka, Hideyuki Hayashi
Publikováno v:
Journal of Clinical Oncology. 39:TPS3141-TPS3141
TPS3141 Background: The human epidermal growth factor receptor 2 (HER2) gene amplification and mutations have emerged as oncogenic drivers and therapeutic targets not limited to breast and gastric cancers, but also in a variety of cancers. However, e
Prognostic significance of α1,6-fucosyltransferase (α1,6-FT) in non-small cell lung cancers (NSCLCs)
Autor:
Ichiro Kinoshita, Naoyuki Taniguchi, Yoshihiro Matsuno, Rio Honma, Eiji Miyoshi, Utano Tomaru, Yasushi Shimizu, Kichizo Kaga, Satoshi Takeuchi, Hirotoshi Akita
Publikováno v:
Journal of Clinical Oncology. 31:7550-7550
7550 Background: Lung cancer is one of the leading causes of cancer death throughout the world. A more sophisticated understanding of the pathogenesis and biology of NSCLCs could provide useful information for predicting clinical outcome and individu
Autor:
Kichizo Kaga, Hirotoshi Akita, Ichiro Kinoshita, Yasushi Shimizu, Naoyuki Taniguchi, Rio Honma, Eiji Miyoshi, Yoshihiro Matsuno
Publikováno v:
Journal of Clinical Oncology. 30:e17520-e17520
e17520 Background: α1,6-FT, a key enzyme for the core fucosylation of N-glycans, has been shown to be needed for the function of EGF and TGF-β1 receptors. α1,6-FT expression is found in human normal bronchial epithelial cells and bronchial gland c